J Korean Diabetes.  2022 Jun;23(2):128-132. 10.4093/jkd.2022.23.2.128.

Management of Diabetes in the Elderly

• Kim SY

• KMID: 2531496
• DOI: http://doi.org/10.4093/jkd.2022.23.2.128

Abstract

As the aging population increases, the number of elderly diabetic patients continues to increase. Elderly diabetic patients are more likely to develop cardiovascular and cerebrovascular diseases than other age groups because of the increased susceptibility to other diseases caused by diabetes. As a result, the quality of life is reduced and the death rate is increasing, which is considered a social problem. Therefore, in order to manage such patients, it is necessary to understand the characteristics of the elderly and solve problems that can occur in elderly diabetic patients.

Keyword

Diabetes management; Elderly diabetic patients; Geriatric syndrome

Reference

1.Centers for Disease Control and Prevention. National diabetes statistics report, 2020. Estimates of diabetes and its burden in the United States. Available from:. www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.

2.Korean Diabetes Association. Diabetes fact sheet in Korea 2020. Seoul: Korean Diabetes Association;2020. p. 6.

3.Sinclair A., Dunning T., Rodriguez Mañas L., Munshi MN. Diabetes in old age. Chichester: Wiley-Blackwell;2017.

4.American Diabetes Association. 12. Older adults: standards of Medical Care in Diabetes-2020. Diabetes Care. 2020. 43(Suppl 1):S152–62.

5.ADVANCE Collaborative Group. Patel A., MacMahon S., Chalmers J., Neal B., Billot L. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008. 358:2560–72.

6.Action to Control Cardiovascular Risk in Diabetes Study Group. Gerstein HC., Miller ME., Byington RP., Goff DC Jr., Bigger JT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008. 358:2545–59.

7.Choi BS., Kim S., Park SC., Shim SH., Song HR., Chang SH. Survey of depression in the elderly patients with diabetes mellitus. J Korean Neuropsychiatr Assoc. 2015. 54:475–81.

8.Kim HA., Shin JY., Kim MH., Park BJ. Prevalence and pre-dictors of polypharmacy among Korean elderly. PLoS One. 2014. 9:e98043.

9.Shin W., Song JS., Kim J. Polypharmacy management program: current status and emerging challenges in older patients. Korean J Clin Geri. 2021. 22:55–60.

10.Lee SH., Han K., Cho H., Park YM., Kwon HS., Kang G. Variability in metabolic parameters and risk of demen-tia: a nationwide population-based study. Alzheimers Res Ther. 2018. 10:110.

11.Lee JH., Hong AR., Kim JH., Kim KM., Koo BK., Shin CS. Amount of smoking, pulmonary function, and bone mineral density in middle-aged Korean men: KNHANES 2008-2011. J Bone Miner Metab. 2018. 36:95–102.

12.Valencia WM., Florez H. Pharmacological treatment of diabetes in older people. Diabetes Obes Metab. 2014. 16:1192–203.

13.Schernthaner G., Grimaldi A., Di Mario U., Drzewoski J., Kempler P., Kvapil M. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 2004. 34:535–42.

14.Loke YK., Singh S., Furberg CD. Long-term use of thiazoli-dinediones and fractures in type 2 diabetes: a meta-analy-sis. CMAJ. 2009. 180:32–9.

15.Imprialos K., Faselis C., Boutari C., Stavropoulos K., Athy-ros V., Karagiannis A. SGLT-2 inhibitors and cardiovascular risk in diabetes mellitus: a comprehensive and critical review of the literature. Curr Pharm Des. 2017. 23:1510–21.

16.Sinclair AJ., Bode B., Harris S., Vijapurkar U., Shaw W., Desai M. Efficacy and safety of canagliflozin in individuals aged 75 and older with type 2 diabetes mellitus: a pooled analysis. J Am Geriatr Soc. 2016. 64:543–52.

17.Davies MJ., D'Alessio DA., Fradkin J., Kernan WN., Mathieu C., Mingrone G. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018. 41:2669–701.

18.Evert AB., Franz MJ. American Diabetes Association guide to nutrition therapy for diabetes. 3rd ed.Arlington: American Diabetes Association;2017.

19.Look AHEAD Research Group. Wing RR., Bolin P., Bran-cati FL., Bray GA., Clark JM. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013. 369:145–54. Erratum in: N Engl J Med 2014; 370:1866.

20.Kim SH., Kim YM., Won YJ. Association of diabetes mellitus and sarcopenia in Korean adults. Korean J Clin Geri. 2018. 19:89–95.

21.Kim SH., Suh YS., Kim DH. Effect of exercise program on physical strength and function in elderly. Korean J Clin Geri. 2014. 15:62–8.